methyldopa has been researched along with digoxin in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (50.00) | 18.7374 |
1990's | 1 (2.78) | 18.2507 |
2000's | 6 (16.67) | 29.6817 |
2010's | 11 (30.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Fishel, B; Herzberg, M; Wiener, MH | 1 |
Falase, AO | 1 |
Markenson, JA; Sherman, RL | 1 |
Kennedy, RD | 1 |
Levine, L | 1 |
Grille, W; Johnsen, K; Kolenda, KD | 1 |
Cohen, P; McGrath, P; Newman, R; Spector, R; Uretsky, N | 1 |
Lees, KR; Rubin, PC | 1 |
Hunt, D; Peter, T; Sloman, G; Vohra, J | 1 |
Amsterdam, EA; Mason, DT; Vismara, LA | 1 |
Haft, JI; Kranz, PD; Shahabadi, AE; Venkatachalapathy, D | 1 |
Gunnar, RM; Loeb, HS; Rahimtoola, SH; Rosen, KM; Sinno, MZ | 1 |
Dietmann, K | 1 |
Lamont, NM; Posel, K | 1 |
Hancock, EW | 1 |
Jain, A; Nicolle, FI; Sanders, CV | 1 |
Bigger, JT; Davis, JC; Reiffel, JA | 1 |
Love, EJ; Patten, SB | 1 |
FRANK, MJ; LASKER, N; LEVINSON, GE; PACIFICO, AD | 1 |
Hirai, S | 1 |
4 review(s) available for methyldopa and digoxin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug therapy for cardiovascular disease in the aged.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Bacterial Agents; Arrhythmias, Cardiac; Benzothiadiazines; Cardiac Rehabilitation; Cardiac Surgical Procedures; Cardiovascular Diseases; Coronary Disease; Delayed-Action Preparations; Digoxin; Diuretics; Endocarditis; Female; Heart Failure; Humans; Hypertension; Hypertension, Malignant; Hyperthyroidism; Hypothyroidism; Isosorbide Dinitrate; Male; Methyldopa; Middle Aged; Nitroglycerin; Sodium Chloride Symporter Inhibitors | 1975 |
Reported ocular side effects of the ten most frequently prescribed drugs.
Topics: Acetaminophen; Ampicillin; Brompheniramine; Codeine; Diazepam; Digoxin; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Eye; Eye Diseases; Female; Furosemide; Humans; Hydrochlorothiazide; Methyldopa; Phenylephrine; Phenylpropanolamine; Pregnancy; Propranolol; Tetracyclines; Triamterene | 1979 |
[Dementia induced by cardiokinetic and anti-hypertensive drugs].
Topics: Antihypertensive Agents; Cardiotonic Agents; Clonidine; Dementia; Digitoxin; Digoxin; Half-Life; Humans; Methyldopa; Propranolol; Reserpine | 2004 |
2 trial(s) available for methyldopa and digoxin
Article | Year |
---|---|
Does intervention by a nurse improve medication compliance?
Topics: Aged; Digoxin; Drug Therapy; Evaluation Studies as Topic; Female; Humans; Male; Methyldopa; Middle Aged; Nurse Practitioners; Patient Compliance | 1978 |
Disopyramide phosphate: clinical efficacy of a new oral antiarrhythmic drug.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzothiadiazines; Digoxin; Disopyramide; Diuretics; Electrocardiography; Female; Humans; Male; Methyldopa; Middle Aged; Placebos; Potassium Chloride; Pyridines; Sodium Chloride Symporter Inhibitors; Tachycardia | 1974 |
30 other study(ies) available for methyldopa and digoxin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Hepatic microsomal enzyme induction and its evaluation in a clinical laboratory.
Topics: Adult; Aged; Diazepam; Digoxin; Enzyme Induction; Female; Furosemide; gamma-Glutamyltransferase; Glucaric Acid; Humans; Male; Methyldopa; Microsomes, Liver; Middle Aged; Quinidine | 1977 |
Cardiomegaly of unknown origin among Nigerian adults: role of hypertension in its aetiology.
Topics: Adolescent; Adult; Aged; Alcoholic Beverages; Benzothiadiazines; Blood Pressure; Cardiomegaly; Cardiomyopathies; Child; Diet; Digoxin; Diuretics; Female; Furosemide; Heart Failure; Humans; Hypertension; Male; Methyldopa; Middle Aged; Nigeria; Sodium Chloride Symporter Inhibitors | 1977 |
Renal involvement in progressive systemic sclerosis: prolonged survival with aggressive antihypertensive management.
Topics: Adult; Antihypertensive Agents; Cardiomegaly; Digoxin; Drug Therapy, Combination; Female; Furosemide; Humans; Hydralazine; Hypertension, Malignant; Hypertension, Renal; Kidney Diseases; Methyldopa; Minoxidil; Propranolol; Scleroderma, Systemic; Time Factors | 1979 |
[Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out-patients (author's transl)].
Topics: Buformin; Diabetes Mellitus; Digoxin; Drug Interactions; Enzyme Inhibitors; Half-Life; Humans; Methyldopa; Phenprocoumon; Tolbutamide | 1979 |
Treatment of cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Antihypertensive Agents; Digoxin; Female; Humans; Lidocaine; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Quinidine | 1987 |
Verapamil induced premature ventricular beats before reversion of supraventricular tachycardia.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Bradycardia; Digoxin; Electrocardiography; Female; Heart Ventricles; Humans; Injections, Intravenous; Male; Methyldopa; Middle Aged; Syndrome; Tachycardia; Tachycardia, Paroxysmal; Verapamil; Wolff-Parkinson-White Syndrome | 1974 |
Orally administered methyldopa. Hemodynamic effects in the presence and absence of congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Digoxin; Heart Failure; Heart Rate; Hemodynamics; Humans; Hypertension; Methyldopa; Middle Aged | 1974 |
Cardiac conduction in patients with symptomatic sinus node disease.
Topics: Aged; Arrhythmia, Sinus; Atropine; Bundle-Branch Block; Digoxin; Electrocardiography; Female; Heart Block; Heart Conduction System; Heart Rate; Humans; Male; Methyldopa; Middle Aged; Pacemaker, Artificial; Sinoatrial Node | 1971 |
[Promotion of organ circulation by raubasine].
Topics: Animals; Arteries; Blood Circulation; Blood Flow Velocity; Blood Pressure; Blood Volume; Cardiac Output; Coronary Vessels; Digoxin; Dogs; Guinea Pigs; Heart Rate; Methyldopa; Myocardium; Oxygen Consumption; Rats; Reserpine; Strophanthins; Vascular Resistance; Vasodilator Agents; Veins; Yohimbine | 1967 |
The coronary attack: concepts on its etiology and hemodynamic management.
Topics: Aged; Arrhythmias, Cardiac; Aspartate Aminotransferases; Biophysical Phenomena; Biophysics; Blood Flow Velocity; Blood Pressure; Cardiac Output; Coronary Disease; Digoxin; Electrocardiography; Heart; Heart Failure; Humans; Hydrocortisone; Hypotension; Isoproterenol; Lidocaine; Male; Methyldopa; Middle Aged; Models, Biological; Propranolol; Stress, Psychological; Veins | 1969 |
Bigeminal rhythm on multiple cardiac drug therapy.
Topics: Arrhythmias, Cardiac; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Electrocardiography; Furosemide; Humans; Hydrochlorothiazide; Male; Methyldopa; Middle Aged; Nitroglycerin; Potassium Chloride; Quinidine | 1984 |
Drug fever during treatment of pulmonary edema.
Topics: Aminophylline; Blood Pressure; Digoxin; Fever; Furosemide; Humans; Hydralazine; Male; Methyldopa; Middle Aged; Pulmonary Edema | 1982 |
Sinus node dysfunction caused by methyldopa and digoxin.
Topics: Aged; Digoxin; Drug Synergism; Female; Heart Failure; Heart Ventricles; Humans; Hypertension; Methyldopa; Sick Sinus Syndrome | 1981 |
Neuropsychiatric adverse drug reactions: passive reports to Health and Welfare Canada's adverse drug reaction database (1965-present).
Topics: Adverse Drug Reaction Reporting Systems; Benzodiazepines; Canada; Databases, Factual; Delirium; Digoxin; Hallucinations; Histamine Agonists; Humans; Methyldopa; Mood Disorders; Substance-Related Disorders | 1994 |
CARDIOVASCULAR FUNCTION IN PERITONEAL DIALYSIS.
Topics: Anemia; Blood Pressure; Blood Pressure Determination; Blood Urea Nitrogen; Blood Volume; Cardiac Catheterization; Cardiac Output; Cardiovascular System; Dialysis; Digoxin; Drug Therapy; Glomerulonephritis; Guanethidine; Humans; Methyldopa; Peritoneal Dialysis; Pyelonephritis; Renal Dialysis; Urine | 1965 |